Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Left Main Chronic Total Occlusion Percutaneous Coronary Intervention: A Case Series.

Xenogiannis I, Karmpaliotis D, Alaswad K, Basir MB, Yeh RW, Tamez H, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Khatri JJ, Sheikh AM, Malik BA, Greene ME, Abi Rafeh N, Maalouf A, Abou Jaoudeh F, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Gkargkoulas F, Russo J, Hakemi E, Tajti P, Hall AB, Vemmou E, Nikolakopoulos I, Rangan BV, Abdullah S, Banerjee S, Brilakis ES.

J Invasive Cardiol. 2019 Jul;31(7):E220-E225.

2.

Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study.

Strom JB, Tamez H, Zhao Y, Valsdottir LR, Curtis J, Brennan JM, Shen C, Popma JJ, Mauri L, Yeh RW.

Am Heart J. 2019 Jun;212:64-71. doi: 10.1016/j.ahj.2019.02.007. Epub 2019 Mar 6.

PMID:
30953936
3.

Depression and Angina Among Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention: The OPEN-CTO Registry.

Yeh RW, Tamez H, Secemsky EA, Grantham JA, Sapontis J, Spertus JA, Cohen DJ, Nicholson WJ, Gosch K, Jones PG, Valsdottir LR, Bruckel J, Lombardi WL, Jaffer FA.

JACC Cardiovasc Interv. 2019 Apr 8;12(7):651-658. doi: 10.1016/j.jcin.2018.12.029. Epub 2019 Mar 13.

PMID:
30878475
4.

Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry.

Secemsky EA, Ferro EG, Rao SV, Kirtane A, Tamez H, Zakroysky P, Wojdyla D, Bradley SM, Cohen DJ, Yeh RW.

JAMA Cardiol. 2019 Feb 1;4(2):110-118. doi: 10.1001/jamacardio.2018.4472.

PMID:
30624549
5.

Contemporary Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention in the United States: An Analysis of the National Cardiovascular Data Registry Research to Practice Initiative.

Valle JA, Tamez H, Abbott JD, Moussa ID, Messenger JC, Waldo SW, Kennedy KF, Masoudi FA, Yeh RW.

JAMA Cardiol. 2019 Feb 1;4(2):100-109. doi: 10.1001/jamacardio.2018.4376.

PMID:
30601910
6.

Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study.

Tamez H, Généreux P, Yeh RW, Amin AP, Fan W, White HD, Kirtane AJ, Stone GW, Gibson CM, Harrington RA, Bhatt DL, Pinto DS; CHAMPION PHOENIX ECONOMICS Investigators.

Catheter Cardiovasc Interv. 2018 Nov 1;92(5):E348-E355. doi: 10.1002/ccd.27638. Epub 2018 May 4.

PMID:
29726596
7.

Rate of Unverifiable Publications Among Ophthalmology Residency Applicants Invited to Interview.

Tamez HM, Tauscher R, Brown EN, Wayman L, Mawn LA.

JAMA Ophthalmol. 2018 Jun 1;136(6):630-635. doi: 10.1001/jamaophthalmol.2018.0846.

8.

Preparing interventional Fellows for advanced training in structural heart disease interventions.

Kalra A, Andalib A, Ramadan R, Hafiz AM, Poulin MF, Tamez H, Pinto DS, Popma JJ.

Eur Heart J. 2017 Mar 7;38(10):701-703. doi: 10.1093/eurheartj/ehx060. No abstract available.

PMID:
28938726
9.

Ocular Amyloidosis.

Tamez H, Patel S, Agarwal A.

Ophthalmology. 2017 Sep;124(9):1367. doi: 10.1016/j.ophtha.2017.02.029. No abstract available.

PMID:
28823350
10.

The chick eye in vision research: An excellent model for the study of ocular disease.

Wisely CE, Sayed JA, Tamez H, Zelinka C, Abdel-Rahman MH, Fischer AJ, Cebulla CM.

Prog Retin Eye Res. 2017 Nov;61:72-97. doi: 10.1016/j.preteyeres.2017.06.004. Epub 2017 Jun 28. Review.

11.

Novel Method for Exchange of Impella Circulatory Assist Catheter: The "Trojan Horse" Technique.

Phillips CT, Tamez H, Tu TM, Yeh RW, Pinto DS.

J Invasive Cardiol. 2017 Jul;29(7):250-252. Epub 2017 May 15.

12.

Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI: A Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial.

Tamez H, Pinto DS, Kirtane AJ, Litherland C, Yeh RW, Dangas GD, Mehran R, Deliargyris EN, Ortiz G, Gibson CM, Stone GW.

JAMA Cardiol. 2017 Jun 1;2(6):673-677. doi: 10.1001/jamacardio.2016.5669.

13.

Review of the Treatment of Periocular Infantile Hemangiomas With Beta Blockers.

Tamez HM, Sobel R.

Int Ophthalmol Clin. 2017 Winter;57(1):169-176. Review. No abstract available.

PMID:
27898622
14.

Serum phospholipid fraction of polyunsaturated fatty acids is the preferred indicator for nutrition and health status in hemodialysis patients.

Watkins BA, Kim J, Tamez H, Wenger J, Thadhani R, Friedman AN.

J Nutr Biochem. 2016 Dec;38:18-24. doi: 10.1016/j.jnutbio.2016.07.021. Epub 2016 Aug 26.

15.

Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes.

Yang X, Tamez H, Lai C, Ho K, Cutlip D.

Catheter Cardiovasc Interv. 2017 Apr;89(5):849-856. doi: 10.1002/ccd.26688. Epub 2016 Aug 18.

PMID:
27535209
16.

Procedure Logging in Interventional Cardiology Training Curriculum: The Interventional Fellows' T-Score.

Kalra A, Hafiz AM, Tamez H.

J Am Coll Cardiol. 2016 Jun 14;67(23):2798-2801. doi: 10.1016/j.jacc.2016.05.001. No abstract available.

17.

African Americans with left ventricular hypertrophy and chronic kidney disease: what should we do?

Tamez H.

Nephrol Dial Transplant. 2016 Dec;31(12):1969-1970. Epub 2016 Jun 9. No abstract available.

PMID:
27282167
18.

Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus.

Tamez HE, Tamez AL, Garza LA, Hernandez MI, Polanco AC.

J Diabetes Metab Disord. 2015 Oct 9;14:78. doi: 10.1186/s40200-015-0210-x. eCollection 2015.

19.

Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia.

Thadhani R, Hagmann H, Schaarschmidt W, Roth B, Cingoez T, Karumanchi SA, Wenger J, Lucchesi KJ, Tamez H, Lindner T, Fridman A, Thome U, Kribs A, Danner M, Hamacher S, Mallmann P, Stepan H, Benzing T.

J Am Soc Nephrol. 2016 Mar;27(3):903-13. doi: 10.1681/ASN.2015020157. Epub 2015 Sep 24.

20.

Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study.

Allegretti AS, Ortiz G, Wenger J, Deferio JJ, Wibecan J, Kalim S, Tamez H, Chung RT, Karumanchi SA, Thadhani RI.

Int J Nephrol. 2015;2015:108139. doi: 10.1155/2015/108139. Epub 2015 Jul 22.

21.

Nutritional vitamin D supplementation in dialysis: a randomized trial.

Bhan I, Dobens D, Tamez H, Deferio JJ, Li YC, Warren HS, Ankers E, Wenger J, Tucker JK, Trottier C, Pathan F, Kalim S, Nigwekar SU, Thadhani R.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):611-9. doi: 10.2215/CJN.06910714. Epub 2015 Mar 13.

22.

Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD).

Nigwekar SU, Tamez H, Thadhani RI.

Bonekey Rep. 2014 Feb 5;3:498. doi: 10.1038/bonekey.2013.232. eCollection 2014.

23.

Vitamin D-binding protein and vitamin D status of black Americans and white Americans.

Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, Powe NR, Thadhani R.

N Engl J Med. 2013 Nov 21;369(21):1991-2000. doi: 10.1056/NEJMoa1306357.

24.

Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease.

Kalim S, Tamez H, Wenger J, Ankers E, Trottier CA, Deferio JJ, Berg AH, Karumanchi SA, Thadhani RI.

Clin J Am Soc Nephrol. 2013 Nov;8(11):1927-34. doi: 10.2215/CJN.04310413. Epub 2013 Aug 22.

25.

Active vitamin D treatment for reduction of residual proteinuria: a systematic review.

de Borst MH, Hajhosseiny R, Tamez H, Wenger J, Thadhani R, Goldsmith DJ.

J Am Soc Nephrol. 2013 Nov;24(11):1863-71. doi: 10.1681/ASN.2013030203. Epub 2013 Aug 8. Review.

26.

Fatty acids and other risk factors for sudden cardiac death in patients starting hemodialysis.

Friedman AN, Yu Z, Denski C, Tamez H, Wenger J, Thadhani R, Li Y, Watkins B.

Am J Nephrol. 2013;38(1):12-8. doi: 10.1159/000351764. Epub 2013 Jun 25.

27.

Impact of new vitamin D data on future studies and treatment.

Bhan I, Tamez H, Thadhani R.

Curr Opin Nephrol Hypertens. 2013 Jul;22(4):377-82. doi: 10.1097/MNH.0b013e3283621408. Review.

28.

Reply to "The role of fibroblast growth factor-23 in left atrial volume".

Tamez H, Andress D, Solomon SD, Thadhani R.

Am Heart J. 2013 May;165(5):e23. doi: 10.1016/j.ahj.2013.02.023. Epub 2013 Mar 27. No abstract available.

PMID:
23622924
29.

Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis.

Friedman AN, Yu Z, Tabbey R, Denski C, Tamez H, Wenger J, Thadhani R, Li Y, Watkins BA.

Kidney Int. 2013 Jun;83(6):1130-5. doi: 10.1038/ki.2013.4. Epub 2013 Feb 6.

30.

Does vitamin D modulate blood pressure?

Tamez H, Kalim S, Thadhani RI.

Curr Opin Nephrol Hypertens. 2013 Mar;22(2):204-9. doi: 10.1097/MNH.0b013e32835d919b. Review.

31.

Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease.

Tamez H, Zoccali C, Packham D, Wenger J, Bhan I, Appelbaum E, Pritchett Y, Chang Y, Agarwal R, Wanner C, Lloyd-Jones D, Cannata J, Thompson BT, Andress D, Zhang W, Singh B, Zehnder D, Pachika A, Manning WJ, Shah A, Solomon SD, Thadhani R.

Am Heart J. 2012 Dec;164(6):902-9.e2. doi: 10.1016/j.ahj.2012.09.018. Epub 2012 Oct 29.

PMID:
23194491
32.

Low blood levels of long-chain n-3 polyunsaturated fatty acids in US hemodialysis patients: clinical implications.

Friedman AN, Yu Z, Tabbey R, Denski C, Tamez H, Wenger J, Thadhani R, Li Y, Watkins BA.

Am J Nephrol. 2012;36(5):451-8. doi: 10.1159/000343741. Epub 2012 Nov 2.

33.

Vitamin D and hypertension: an update and review.

Tamez H, Thadhani RI.

Curr Opin Nephrol Hypertens. 2012 Sep;21(5):492-9. doi: 10.1097/MNH.0b013e3283557bf0. Review.

PMID:
22820371
34.

Vitamin D Therapy and Cardiac Function in Chronic Kidney Disease-Reply.

Thadhani R, Tamez H, Solomon SD.

JAMA. 2012 Jun 6;307(21):2253. No abstract available.

PMID:
24104200
35.

Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.

Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, Bhan I, Agarwal R, Zoccali C, Wanner C, Lloyd-Jones D, Cannata J, Thompson BT, Andress D, Zhang W, Packham D, Singh B, Zehnder D, Shah A, Pachika A, Manning WJ, Solomon SD.

JAMA. 2012 Feb 15;307(7):674-84. doi: 10.1001/jama.2012.120.

PMID:
22337679
36.

Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease.

Khankin EV, Mutter WP, Tamez H, Yuan HT, Karumanchi SA, Thadhani R.

PLoS One. 2010 Feb 16;5(2):e9246. doi: 10.1371/journal.pone.0009246.

37.

Klotho variants and chronic hemodialysis mortality.

Friedman DJ, Afkarian M, Tamez H, Bhan I, Isakova T, Wolf M, Ankers E, Ye J, Tonelli M, Zoccali C, Kuro-o M, Moe O, Karumanchi SA, Thadhani R.

J Bone Miner Res. 2009 Nov;24(11):1847-55. doi: 10.1359/jbmr.090516.

38.

Plasma gelsolin and circulating actin correlate with hemodialysis mortality.

Lee PS, Sampath K, Karumanchi SA, Tamez H, Bhan I, Isakova T, Gutierrez OM, Wolf M, Chang Y, Stossel TP, Thadhani R.

J Am Soc Nephrol. 2009 May;20(5):1140-8. doi: 10.1681/ASN.2008091008. Epub 2009 Apr 23.

39.

Risk for developing gestational diabetes in women with twin pregnancies.

Rauh-Hain JA, Rana S, Tamez H, Wang A, Cohen B, Cohen A, Brown F, Ecker JL, Karumanchi SA, Thadhani R.

J Matern Fetal Neonatal Med. 2009 Apr;22(4):293-9. doi: 10.1080/14767050802663194.

PMID:
19340713
40.

Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis.

Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo CA Jr, Koeffler HP, Thadhani R.

Clin Infect Dis. 2009 Feb 15;48(4):418-24. doi: 10.1086/596314.

PMID:
19133797
41.

Phosphorus binders and survival on hemodialysis.

Isakova T, Gutiérrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf M.

J Am Soc Nephrol. 2009 Feb;20(2):388-96. doi: 10.1681/ASN.2008060609. Epub 2008 Dec 17.

42.

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.

Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M.

N Engl J Med. 2008 Aug 7;359(6):584-92. doi: 10.1056/NEJMoa0706130.

43.

N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements.

Gutiérrez OM, Tamez H, Bhan I, Zazra J, Tonelli M, Wolf M, Januzzi JL, Chang Y, Thadhani R.

Clin Chem. 2008 Aug;54(8):1339-48. doi: 10.1373/clinchem.2007.101691. Epub 2008 Jun 6.

44.

Impact of activated vitamin D and race on survival among hemodialysis patients.

Wolf M, Betancourt J, Chang Y, Shah A, Teng M, Tamez H, Gutierrez O, Camargo CA Jr, Melamed M, Norris K, Stampfer MJ, Powe NR, Thadhani R.

J Am Soc Nephrol. 2008 Jul;19(7):1379-88. doi: 10.1681/ASN.2007091002. Epub 2008 Apr 9.

45.

Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals.

Bodyak N, Ayus JC, Achinger S, Shivalingappa V, Ke Q, Chen YS, Rigor DL, Stillman I, Tamez H, Kroeger PE, Wu-Wong RR, Karumanchi SA, Thadhani R, Kang PM.

Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16810-5. Epub 2007 Oct 17.

46.

Vitamin D levels and early mortality among incident hemodialysis patients.

Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R.

Kidney Int. 2007 Oct;72(8):1004-13. Epub 2007 Aug 8.

47.

Visual vignette.

Tamez HE, Cedillo J, Gutierrez H, Mora N, Forsbach G.

Endocr Pract. 2007 Jul-Aug;13(4):430. No abstract available.

PMID:
17669725
48.

Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.

Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R.

Hypertension. 2007 Jul;50(1):137-42. Epub 2007 May 21.

PMID:
17515455
49.

[Impact of the new criteria for the diagnosis of gestational diabetes on the estimate of its prevalence].

Forsbach-Sanchez G, Gonzalez-Obele E, Villanueva-Cuellar MA, Tamez HE, Rocha-Marquez J.

Rev Invest Clin. 2003 Sep-Oct;55(5):507-10. Spanish.

PMID:
14968471
50.

Amigos Del Valle.

Tamez H, Hyslin NG.

Aging. 1980 Mar-Apr;(305-6):15-9. No abstract available.

PMID:
10246528

Supplemental Content

Support Center